Translational Research Cancer Centers Consortium
21st TRCCC Annual Meeting
February 14-16, 2018
Seven Springs, PA
John Hopkins Medicine
Mary Babb Randolph Cancer Center at West Virginia University
University of Michigan Comprehensive Cancer Center
The James, The Ohio State University Comprehensive Cancer Center
Penn State Hershey Cancer Institute
University of Rochester
Roswell Park Cancer Institute
University of Pittsburgh Cancer Institute
Click here for sponsorship Information.
Contact: Stephen T. Haley, Ph.D
SH@immudex.com or (301) 606-9145
if you are interested in sponsoring the TRCCC Annual Meeting .
Richard Goldberg, M.D.
Laurence S. & Jean J. DeLynn Chair of Oncology,
Director; WVU Cancer Institute, West Virginia University
Robert L. Ferris, MD, PhD
Director, UPMC Hillman Cancer Center
Hillman Professor of Oncology
Co-Director, Tumor Microenvironment Center
Associate Vice-Chancellor for Cancer Research
Professor of Otolaryngology, Immunology, and Radiation Oncology, University of Pittsburgh School of Medicine
Pamela S Ohashi, PhD, FRSC
Professor, Department of Immunology and Medical Biophysics, University of Toronto;
Director, Immune Therapy Program, Ontario Cancer Institute
Co-Director, Campbell Family Institute for Breast Cancer Research
Senior Scientist, Ontario Cancer Institute/Princess Margaret Cancer Centre, University Health Network
Canada Research Chair in Autoimmunity and Tumour Immunity
Laura F. Gibson, Ph.D.
Senior Associate Vice President for Research & Graduate Education,
Associate Dean for Research, School of Medicine,
Deputy Director; WVU Cancer Institute,
Alexander B. Osborn Distinguished Professor, West Virginia University
David Klinke, Ph.D.
Associate Professor of Chemical and Biomedical Engineering
Statler College of Engineering and Mineral Resources and WVU Cancer InstituteWest Virginia University